Funding
Who raised, when, and from whom? Explore announced rounds, including emerging Indian companies, and company-reported SEC notices. Each amount keeps its original source and date.
1,460 filings · Form D notices of private raises, 2024-01-02 to 2026-03-31
Naveris, Inc.Biotechnology
Waltham, Massachusetts · Equity · 5 investors · James McNally, Anne Stone
DiaMedica Therapeutics Inc.Biotechnology
Minneapolis, Minnesota · Equity · 10 investors · David Wambeke, Charles Semba
Continuity Biosciences, LLCBiotechnology
Bradenton, Florida
SANUWAVE Health, Inc.Biotechnology
Eden Prairie, Minnesota · Debt, Options, Convertible · 9 investors · Peter Stegano, Andrew Walko
NeuroBo Pharmaceuticals, Inc.Biotechnology
Cambridge, Massachusetts · Equity, Options, Convertible · 2 investors · D. Strickland, James Tursi
Oleander Medical Technologies LLCBiotechnology
Baton Rouge, Louisiana · Equity · 4 investors · Paige Miller, Harry Gould III
Gnosko Bio Inc.Biotechnology
Wayne, Pennsylvania · founded 2024 · Equity · 2 investors · Sam Agris, Danielle Brady
Celcuity Inc.Biotechnology
Minneapolis, Minnesota · Debt, Options, Convertible · 2 investors · Lance Laing, Polly Murphy
KALA BIO, Inc.Biotechnology
Arlington, Massachusetts · Equity · 5 investors · Mark Iwicki, Kim Brazzell
Tharimmune, Inc.Biotechnology
Bridgewater, New Jersey · Equity, Options, Convertible · 5 investors · Randy Milby, Kelly Anderson
Navrogen Inc.Biotechnology
Cheyney, Pennsylvania · Convertible Debt · 13 investors · Allan Bedwick, Luigi Grasso
Hexamer Therapeutics, IncBiotechnology
Pullman, Washington · founded 2019 · Equity, Options · 9 investors · Robert Bogden, Keith Miller
Navrogen Inc.Biotechnology
Cheyney, Pennsylvania · Convertible Debt · 13 investors · Nicholas Nicolaides, Luigi Grasso
Elion Therapeutics, Inc.Biotechnology
New York, New York · Equity · 6 investors · Jim Flynn, Kieren Marr
Phi Therapeutics, Inc.Biotechnology
Petaluma, California · Equity, Options · 22 investors · Jun Li, Yug Varma
Cerecin Inc.Biotechnology
Denver, Colorado · Debt, Convertible promissory notes convertible into equity securities of the Iss · 10 investors · Jerris Knaisch, Claude Nash
Amend Surgical, Inc.Biotechnology
Gainesville, Florida · Equity · 5 investors · Ronald Cobb, James Kirk
Amplifi Vascular, Inc.Biotechnology
Wilmington, Delaware · founded 2023 · Equity · 6 investors · Sean Morris, Steve Braun
Marea Therapeutics, Inc.Biotechnology
San Francisco, California · founded 2021 · Equity · 10 investors · Mark Joing, Jeff Tong
MUSTANG BIO, INC.Biotechnology
Worcester, Massachusetts · Options, Convertible · 1 investors · Manuel Litchman, M.D., Adam Chill
Nexsis Biosciences LLCBiotechnology
St. Augustine, Florida · founded 2021 · Equity · 13 investors · Beecher Lewis, Scott Cart
Koios Medical, Inc.Biotechnology
New York, New York · Debt · 4 investors · Graham Anderson, Robert McClennan
Ingenia Therapeutics Inc.Biotechnology
Watertown, Massachusetts · Equity · 1 investors · Sang Gyun Kim, Eric Furfine
Microbot Medical Inc.Biotechnology
Braintree, Massachusetts · Equity, Options, Convertible · 3 investors · Aileen Stockburger, Martin Madden
RCE Technologies, Inc.Biotechnology
Carlsbad, California · Debt, Options, Convertible · 18 investors · Mintu Turakhia, Atandra Burman
Summit Therapeutics Inc.Biotechnology
Miami, Florida · founded 2020 · Equity · 2 investors · Yu Xia, Ujwala Mahatme
Kern Australis, LLCBiotechnology
Larkspur, California · founded 2024 · Equity · 31 investors · Kern Capital, LLC, John Kern, Jr.
Greenwich LifeSciences, Inc.Biotechnology
Stafford, Texas · Equity · 1 investors · Kenneth Hallock, Eric Rothe
MicroMed, LLCBiotechnology
Indianapolis, Indiana · Equity · 1 investors · Anders Weaver, James Floyd
Santa Ana Bio, Inc.Biotechnology
Alameda, California · founded 2020 · Equity · 10 investors · Mittie Doyle, Peter Emtage